(In thousands, except per-share amounts)

CompanySymbol/Revenues / ProfitsPer shareR & DCash SharesPeriod% changeCurrent/compCurrent/comp% Changeor Equiv.Alpha 1 BiomedicalsALBM/1Q34/-92%(2,800)/(1,016)(0.31)/(0.13)NA/NANA8,972AprogenexAPG/1Q0/NA#(1,491)/(709)(0.32)/(0.23)902/130%7,2844,635Atrix LaboratoriesATRX/1Q432/-42%(1,426)/(872)(0.18)/(0.11)1,617/20%NA7,736Cantab PharmaceuticalsCNTBY/1Q296/23%(1,159)/(1,151)(0.12)/(0.19)1,445/20%28,8619,837Deprenyl Animal HealthDAHI/1Q16/-77%(658)/(437)(0.10)/(0.07)NA/NA1,6596,484ICN PharmaceuticalsICN/1Q17,202/3%(4,545)/1,063(0.22)/0.061,700/65%18,56620,523IGENIGEN/4Q3,264/-7%(388)/438(0.03)/0.042,527/136%41,74613,309Innovir LaboratoriesINVR/2Q29/2800%(730)/(858)(0.24)/(4.14)467/21%4,0003,046InterPharm LaboratoriesIPLLF/1Q13,441/6%3,708/3,0390.13/0.17NA/NANA6,242Ligand PharmaceuticalsLGNDA/1Q2,343/-21%(6,926)/(3,575)(0.48)/(0.25)36,794/154%36,79414,490Oncogene ScienceONCS/2Q4,131/8%(1,280)/(1,070)(0.07)/(0.05)2,831/12%21,24416,332ParacelsianPRLN/2Q21/NA#(445)/(535)(0.19)/(0.23)NA/NANA2,312SangStat MedicalSANG/1Q986/512%(807)/(1,305)(0.12)/(0.26)1,035/60%10,5956,961Shaman PharmaceuticalsSHMN/1Q520/2%(4,058)/(1,842)(0.31)/(0.24)4,125/89%53,29112,967

# Reported 0 revenues in comparable 1993 quarter.

All Symbols except ICN Pharmaceuticals (NYSE) and Aprogenex(ASE) are NASDAQ

(c) 1997 American Health Consultants. All rights reserved.